After the staff entered the subjects name, gender, age, height and other information, the start button was pressed to begin the scan, which lasted approximately 2 to 5 min
Although semaglutide is effective, many people discontinue it due to high costs, persistent side effects, medication shortages, weight-loss plateaus, reaching their goal weight, or simply feeling physically or mentally tired of long-term injections

Based on the clinical trial population and the medications mechanism, individuals who may benefit most from retatrutide once it becomes available include: Adults with a BMI of 30 or greater (obesity) Adults with a BMI of 27 or greater who have weight-related conditions such as type 2 diabetes, hypertension, dyslipidemia, or sleep apnea Individuals who have not achieved adequate results with semaglutide or tirzepatide Patients seeking greater weight loss than what current medications provide Individuals with metabolic dysfunction-associated steatohepatitis (MASH) given the glucagon receptors role in liver fat metabolism Retatrutide may not be appropriate for individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe gastrointestinal disorders, or a history of pancreatitis
However, these medications should be discontinued before conception and avoided during pregnancy
For individuals serious about achieving sustainable, body-first health improvements, Bioma Probiotic for Weight Loss represents a new frontier in wellness strategy
Meanwhile, to provide historical context, Table 1 presents a timeline of seminal discoveries for key metabolic factors in epilepsy